135 related articles for article (PubMed ID: 37246449)
1. Exploration of s new biomarker in osteosarcoma and association with clinical outcomes:
Xu Y; Chen P; Liu D; Xu Q; Meng H; Wang X
J Gene Med; 2023 Nov; 25(11):e3528. PubMed ID: 37246449
[TBL] [Abstract][Full Text] [Related]
2. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
Gene; 2024 May; 907():148286. PubMed ID: 38367852
[TBL] [Abstract][Full Text] [Related]
3. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
4. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
5. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
8. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
Zhou Z; Guo S; Lai S; Wang T; Du Y; Deng J; Zhang S; Gao G; Zhang J
BMC Cancer; 2023 Jan; 23(1):108. PubMed ID: 36717783
[TBL] [Abstract][Full Text] [Related]
9. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract][Full Text] [Related]
10. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
11. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
12. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data.
Liang C; Ji D; Qin F; Chen G
Medicine (Baltimore); 2023 Mar; 102(10):e33149. PubMed ID: 36897717
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma.
Huang X; Wang L; Guo H; Zhang W; Shao Z
Theranostics; 2022; 12(13):5877-5887. PubMed ID: 35966586
[No Abstract] [Full Text] [Related]
14. Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma.
Wang X; Xie C; Lin L
J Bone Oncol; 2023 Feb; 38():100463. PubMed ID: 36569351
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
16. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
[TBL] [Abstract][Full Text] [Related]
17. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing.
Hu J; Jiang Y; Wei Q; Li B; Xu S; Wei G; Li P; Chen W; Lv W; Xiao X; Lu Y; Huang X
Biomed Res Int; 2022; 2022():2955359. PubMed ID: 36510567
[TBL] [Abstract][Full Text] [Related]
18. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast infiltration in osteosarcoma: the discrepancy in subtypes pathways and immunosuppression.
Zhihao Z; Cheng J; Xiaoshuang Z; Yangguang M; Tingyu W; Yongyong Y; Zhou Y; Jie Z; Tao Z; Xueyu H; Zhe W
Front Pharmacol; 2023; 14():1136960. PubMed ID: 37441535
[No Abstract] [Full Text] [Related]
20. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
